Log in

NASDAQ:EVOKEvoke Pharma News Headlines

$1.08
+0.02 (+1.89 %)
(As of 04/9/2020 04:34 AM ET)
Add
Compare
Today's Range
$1.04
Now: $1.08
$1.13
50-Day Range
$0.82
MA: $1.17
$1.52
52-Week Range
$0.50
Now: $1.08
$1.79
Volume72,600 shs
Average Volume178,880 shs
Market Capitalization$26.17 million
P/E RatioN/A
Dividend YieldN/A
Beta1.83

Headlines

Evoke Pharma (NASDAQ EVOK) News Headlines

Source:
DateHeadline
Short Interest in Evoke Pharma Inc (NASDAQ:EVOK) Drops By 7.9%Short Interest in Evoke Pharma Inc (NASDAQ:EVOK) Drops By 7.9%
www.americanbankingnews.com - March 29 at 6:48 PM
-$0.06 EPS Expected for Evoke Pharma Inc (NASDAQ:EVOK) This Quarter-$0.06 EPS Expected for Evoke Pharma Inc (NASDAQ:EVOK) This Quarter
www.americanbankingnews.com - March 23 at 7:51 PM
Evoke Pharma EPS misses by $0.01Evoke Pharma EPS misses by $0.01
seekingalpha.com - March 12 at 2:56 PM
Evoke Pharma Reports Fourth Quarter and Full Year 2019 Financial ResultsEvoke Pharma Reports Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - March 12 at 2:56 PM
Evoke Pharma Receives Notice of Allowance from USPTO for Gimoti™Evoke Pharma Receives Notice of Allowance from USPTO for Gimoti™
finance.yahoo.com - January 27 at 1:05 PM
BRIEF-Evoke Pharma Enters Commercialization Agreement With EVERSANA Life Sciences For GimotiBRIEF-Evoke Pharma Enters Commercialization Agreement With EVERSANA Life Sciences For Gimoti
www.msn.com - January 23 at 4:30 PM
Evoke Pharma up 10% premarket on Gimoti deal in U.S.Evoke Pharma up 10% premarket on Gimoti deal in U.S.
seekingalpha.com - January 23 at 4:30 PM
Evoke Pharma Enters Commercialization Agreement with EVERSANA Life Sciences for Gimoti™Evoke Pharma Enters Commercialization Agreement with EVERSANA Life Sciences for Gimoti™
finance.yahoo.com - January 23 at 4:30 PM
Evoke Pharmas NDA Resubmission for Gimoti Gets FDA AcceptanceEvoke Pharma's NDA Resubmission for Gimoti Gets FDA Acceptance
www.nasdaq.com - January 22 at 4:51 PM
Evoke Pharma up 19% premarket on FDA acceptance of Gimoti refilingEvoke Pharma up 19% premarket on FDA acceptance of Gimoti refiling
seekingalpha.com - January 21 at 9:00 AM
FDA Accepts Evoke Pharma’s NDA Resubmission for Gimoti™FDA Accepts Evoke Pharma’s NDA Resubmission for Gimoti™
finance.yahoo.com - January 21 at 9:00 AM
Gastroparesis Drugs Market Business Strategies and Top Companies by 2020-2029 | Cadila Pharmaceuticals, GlaxoSmithKline, Johnson & JohnsonGastroparesis Drugs Market Business Strategies and Top Companies by 2020-2029 | Cadila Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson
www.marketwatch.com - December 30 at 4:27 PM
Evoke Resubmits Gimoti™ New Drug Application to FDAEvoke Resubmits Gimoti™ New Drug Application to FDA
finance.yahoo.com - December 20 at 9:14 AM
Evoke Pharma Regains Compliance with Nasdaq Minimum Bid RequirementEvoke Pharma Regains Compliance with Nasdaq Minimum Bid Requirement
finance.yahoo.com - December 2 at 12:08 PM
Evoke Pharma up 32%Evoke Pharma up 32%
seekingalpha.com - November 18 at 6:11 PM
What Kind Of Shareholder Appears On The Evoke Pharma, Inc.s (NASDAQ:EVOK) Shareholder Register?What Kind Of Shareholder Appears On The Evoke Pharma, Inc.'s (NASDAQ:EVOK) Shareholder Register?
finance.yahoo.com - November 18 at 1:11 PM
What Kind Of Shareholder Appears On The Evoke Pharma, Inc.'s (NASDAQ:EVOK) Shareholder Register?What Kind Of Shareholder Appears On The Evoke Pharma, Inc.'s (NASDAQ:EVOK) Shareholder Register?
finance.yahoo.com - November 18 at 1:11 PM
Evoke Pharma Granted 180-Day Extension by Nasdaq Regarding Minimum Bid PriceEvoke Pharma Granted 180-Day Extension by Nasdaq Regarding Minimum Bid Price
finance.yahoo.com - November 13 at 9:13 AM
Evoke Pharma EPS beats by $0.02Evoke Pharma EPS beats by $0.02
seekingalpha.com - November 7 at 12:52 PM
Evoke Pharma Reports Third Quarter 2019 Financial ResultsEvoke Pharma Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 7 at 12:52 PM
When Will Evoke Pharma, Inc. (NASDAQ:EVOK) Come Back To Market?When Will Evoke Pharma, Inc. (NASDAQ:EVOK) Come Back To Market?
finance.yahoo.com - September 19 at 3:46 PM
BRIEF-Evoke Pharma Completed Manufacturing Commercial Scale Batches Of Product Candidate GimotiBRIEF-Evoke Pharma Completed Manufacturing Commercial Scale Batches Of Product Candidate Gimoti
www.msn.com - September 18 at 1:44 PM
Evoke Pharma Completes Manufacturing of Commercial Scale Registration Batches of Gimoti™Evoke Pharma Completes Manufacturing of Commercial Scale Registration Batches of Gimoti™
finance.yahoo.com - September 18 at 1:44 PM
Diabetic Gastroparesis Treatment Market will grow in the upcoming year? Players evolved: Evoke Pharma, Cardinal Health, Salix PharmaceuticalsDiabetic Gastroparesis Treatment Market will grow in the upcoming year? Players evolved: Evoke Pharma, Cardinal Health, Salix Pharmaceuticals
www.marketwatch.com - August 16 at 7:55 PM
Evoke Pharma to Resubmit Gimoti™ NDA Based on FDA Meeting Minutes and Announces Second Quarter 2019 Financial ResultsEvoke Pharma to Resubmit Gimoti™ NDA Based on FDA Meeting Minutes and Announces Second Quarter 2019 Financial Results
finance.yahoo.com - August 8 at 9:33 AM
Updated : Gastroparesis Drugs Market Competitive Insights Of Top Players - GlaxoSmithKline, Johnson & Johnson and Cadila PharmaceuticalsUpdated : Gastroparesis Drugs Market Competitive Insights Of Top Players - GlaxoSmithKline, Johnson & Johnson and Cadila Pharmaceuticals
www.marketwatch.com - July 27 at 12:45 AM
Biotech Stock On The Radar: Evoke Pharma Sets Date With FDABiotech Stock On The Radar: Evoke Pharma Sets Date With FDA
finance.yahoo.com - July 26 at 1:06 AM
Is Evoke Pharma, Inc. (NASDAQ:EVOK) A Volatile Stock?Is Evoke Pharma, Inc. (NASDAQ:EVOK) A Volatile Stock?
finance.yahoo.com - July 11 at 5:55 PM
Evoke Pharma Requests Type A FDA Meeting to Plan for Resubmission of Gimoti™ NDAEvoke Pharma Requests Type A FDA Meeting to Plan for Resubmission of Gimoti™ NDA
www.nasdaq.com - June 27 at 9:01 AM
Evoke Pharma (EVOK) to Post Q1 Earnings: Whats in Store?Evoke Pharma (EVOK) to Post Q1 Earnings: What's in Store?
www.nasdaq.com - May 8 at 7:15 PM
Evoke Pharma Reports First Quarter 2019 Financial ResultsEvoke Pharma Reports First Quarter 2019 Financial Results
finance.yahoo.com - May 8 at 7:15 PM
Investors Who Bought Evoke Pharma (NASDAQ:EVOK) Shares Five Years Ago Are Now Down 92%Investors Who Bought Evoke Pharma (NASDAQ:EVOK) Shares Five Years Ago Are Now Down 92%
finance.yahoo.com - April 29 at 6:23 PM
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial ReadoutsThe Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
feeds.benzinga.com - April 7 at 7:43 PM
Evoke Pharma receives CRL for Gimoti NDA; shares down 38% premarketEvoke Pharma receives CRL for Gimoti NDA; shares down 38% premarket
seekingalpha.com - April 2 at 9:38 AM
Evoke Pharma Receives Complete Response Letter and Recommendations to Address Deficiencies from FDA for Gimoti™ NDAEvoke Pharma Receives Complete Response Letter and Recommendations to Address Deficiencies from FDA for Gimoti™ NDA
finance.yahoo.com - April 2 at 9:38 AM
Evoke Pharma IncEvoke Pharma Inc
www.bloomberg.com - March 19 at 9:11 AM
Evoke Pharma up 19% premarket on response to FDA letter related to Gimoti NDAEvoke Pharma up 19% premarket on response to FDA letter related to Gimoti NDA
seekingalpha.com - March 14 at 6:56 PM
Evoke Pharma Submits Response to FDA Review Letter for Gimoti™ NDAEvoke Pharma Submits Response to FDA Review Letter for Gimoti™ NDA
finance.yahoo.com - March 14 at 9:11 AM
Mid-Afternoon Market Update: Nightstar Therapeutics Surges On Acquisition News; Evoke Pharma Shares Plunge - NasdaqMid-Afternoon Market Update: Nightstar Therapeutics Surges On Acquisition News; Evoke Pharma Shares Plunge - Nasdaq
www.nasdaq.com - March 6 at 9:01 AM
Evoke Pharma Reports Fourth Quarter and Full Year 2018 Financial Results and FDA CommunicationEvoke Pharma Reports Fourth Quarter and Full Year 2018 Financial Results and FDA Communication
finance.yahoo.com - March 6 at 9:01 AM
BRIEF-Evoke Pharma Receives Preliminary FDA Communication On Gimoti NDABRIEF-Evoke Pharma Receives Preliminary FDA Communication On Gimoti NDA
www.msn.com - March 4 at 7:24 PM
Evoke Pharma Inc.Evoke Pharma Inc.
www.barrons.com - March 4 at 7:24 PM
Evoke Pharma receives preliminary FDA communication on Gimoti NDA; shares down 51% premarketEvoke Pharma receives preliminary FDA communication on Gimoti NDA; shares down 51% premarket
seekingalpha.com - March 4 at 7:24 PM
Mid-Morning Market Update: Markets Open Higher; Childrens Place Misses Q4 Expectations - BenzingaMid-Morning Market Update: Markets Open Higher; Childrens Place Misses Q4 Expectations - Benzinga
www.benzinga.com - March 4 at 11:43 AM
Evoke Pharma Receives Preliminary FDA Communication on Gimoti™ NDAEvoke Pharma Receives Preliminary FDA Communication on Gimoti™ NDA
finance.yahoo.com - March 4 at 11:43 AM
Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial ResultsEvoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results
finance.yahoo.com - February 27 at 8:50 AM
Form 8-K Evoke Pharma Inc For: Jan 05 - StreetInsider.comForm 8-K Evoke Pharma Inc For: Jan 05 - StreetInsider.com
www.streetinsider.com - January 7 at 6:00 PM
Evoke Pharma Signs Commercial and Financial Agreement for its Lead Product Gimoti™ in the U.S. with Novos Growth Partners - GlobeNewswireEvoke Pharma Signs Commercial and Financial Agreement for its Lead Product Gimoti™ in the U.S. with Novos Growth Partners - GlobeNewswire
globenewswire.com - January 7 at 6:00 PM
Evoke Pharma Signs Commercial and Financial Agreement for its Lead Product Gimoti™ in the U.S. with Novos Growth PartnersEvoke Pharma Signs Commercial and Financial Agreement for its Lead Product Gimoti™ in the U.S. with Novos Growth Partners
finance.yahoo.com - January 7 at 8:39 AM
Loss-Making Evoke Pharma, Inc. (NASDAQ:EVOK) Expected To BreakevenLoss-Making Evoke Pharma, Inc. (NASDAQ:EVOK) Expected To Breakeven
finance.yahoo.com - January 4 at 10:50 AM
This page was last updated on 4/9/2020 by MarketBeat.com Staff

Featured Article: SEC Filing

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel